RMD - ResMed - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7611521078
Ventilation Devices, Diagnostic Products, Mask Systems, Cloud Software
ResMed Inc. is a leading medical technology company that specializes in developing, manufacturing, and distributing innovative devices and cloud-based software solutions for the healthcare industry.
The company operates through two main segments: Sleep and Respiratory Care, and Software as a Service. The Sleep and Respiratory Care segment focuses on providing a range of products and solutions for respiratory disorders, including ventilation devices, diagnostic products, mask systems, and accessories. These products are designed to be used in both medical and consumer settings, helping to improve patient outcomes and quality of life.
In addition to its hardware offerings, ResMed also provides a suite of cloud-based software solutions that enable healthcare providers to remotely monitor and manage patient care. For example, its AirView system allows healthcare professionals to monitor patients' device settings and make adjustments remotely, while its myAir application provides personalized therapy management and support tools for patients with sleep apnea.
ResMed's Software as a Service segment offers a range of out-of-hospital software solutions, including Brightree business management software, MatrixCare care management solutions, HEALTHCAREfirst electronic health record software, and MEDIFOX DAN's software solutions. These solutions are designed to help healthcare providers streamline their operations, improve patient care, and reduce costs.
The company's products and solutions are marketed to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. With a strong commitment to innovation and customer service, ResMed has established itself as a leader in the healthcare technology industry since its founding in 1989. Today, the company is headquartered in San Diego, California, and continues to drive growth and innovation in the healthcare sector.
For more information about ResMed and its products and solutions, visit their website at https://www.resmed.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
RMD Stock Overview
| Market Cap in USD | 30,091m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC SubIndustry | Health Care Equipment |
| TER | 0.00% |
| IPO / Inception | 1995-06-02 |
RMD Stock Ratings
| Growth 5y | 33.8 |
| Fundamental | 90.2 |
| Dividend | 52.9 |
| Rel. Performance vs Sector | -0.07 |
| Analysts | 3.93/5 |
| Fair Price Momentum | 168.69 USD |
| Fair Price DCF | 192.25 USD |
RMD Dividends
| Dividend Yield 12m | 0.97% |
| Yield on Cost 5y | 1.55% |
| Dividends CAGR 5y | 3.90% |
| Payout Consistency | 100.0% |
RMD Growth Ratios
| Growth 12m | -10.77% |
| Growth Correlation 12m | 57% |
| Growth Correlation 3m | -50% |
| CAGR 5y | 9.70% |
| CAGR/Mean DD 5y | 0.52 |
| Sharpe Ratio 12m | -0.39 |
| Alpha vs SP500 12m | -31.06 |
| Beta vs SP500 5y weekly | 0.97 |
| ValueRay RSI | 33.63 |
| Volatility GJR Garch 1y | 34.97% |
| Price / SMA 50 | -3.89% |
| Price / SMA 200 | 8.09% |
| Current Volume | 1896.8k |
| Average Volume 20d | 987.1k |
External Links for RMD Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 197.04 with a total of 1,896,839 shares traded.
Over the past week, the price has changed by -3.01%, over one month by +5.63%, over three months by -9.44% and over the past year by -10.44%.
According to ValueRays Forecast Model, RMD ResMed will be worth about 187.2 in July 2025. The stock is currently trading at 197.04. This means that the stock has a potential downside of -4.99%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 216.1 | 9.65 |
| Analysts Target Price | 184 | -6.62 |
| ValueRay Target Price | 187.2 | -4.99 |